Sign in
Not yet recruitingPhase 3

Role of Non-Selective Beta-Adrenergic Blocker in Severe TBI

Key facts

Who runs it
Tanta University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
Phase
Phase 3
People taking part
60 people, planned
Started
20 Sept 2025
Planned end
20 Sept 2025
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • propranolol
  • normal saline IV
Record updated
11 March 2025

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Patients aged between 18and 65 years old
  • Patients who have Severe traumatic brain injury
  • Glascow outcome scale ≤ 8

Who cannot take part

  • Patients have pre-existing heart disease
  • If there are contraindications to β blocker
  • penetrating traumatic brain injury
  • pre-injury brain dysfunction
  • β-blocker or α2-agonist use before trauma

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The role of nonselective beta adrenergic blocker as antistress agent in severe traumatic brain injury

The 2 groups in the trial

  • Propranolol groupTreatment being tested

    This group Will receive propranolol intravenously at a dose of 1 mg every 6 h for 7 days.

    Treatment: propranolol

  • normal saline IV groupPlacebo, for comparison

    This group Will receive 1ml of sterile 0.9% normal saline IV every 6 hours for 7 days

    Treatment: normal saline IV

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Role of Non-Selective Beta-Adrenergic Blocker in Severe Traumatic Brain Injury
Criteria questions
Built from NCT06870370, who can take part
Record updated
11 March 2025